Combinations of paclitaxel and withaferin A against human non-small cell lung cancer

(Impact Journals LLC) Oncotarget Volume 11 Issue 16 showed that the sensitivity of H1299 and A549 cells to concomitant treatment with PAC and WFA was greater than that of either PAC or WFA alone.